Eutilex.Co.Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.083x

Eutilex.Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Eutilex.Co.Ltd (263050) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.41 Billion ≈ $-1.63 Million USD) by net assets (₩28.91 Billion ≈ $19.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Eutilex.Co.Ltd (2016–2024)

Cash flow conversion efficiency of Eutilex.Co.Ltd from 2016 to 2024. This chart illustrates how Eutilex.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Eutilex.Co.Ltd (263050) share price today for real-time trading data and today's change.

Eutilex.Co.Ltd Cash Flow Conversion Ratio Explained

Eutilex.Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eutilex.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eutilex.Co.Ltd ranked by their cash flow conversion efficiency. Also see Eutilex.Co.Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Conduril - Engenharia S.A LS:CDU	N/A
Lotus Eye Hospital and Institute Limited NSE:LOTUSEYE	0.008x
Texchem Resources Bhd KLSE:8702	0.153x
Avensia publ AB ST:AVEN	0.349x
R.P.P. Infra Projects Limited NSE:RPPINFRA	0.014x
WITTED MEGACORP OYJ EO 1 F:8OS	0.106x
KB Autosys Co. Ltd KQ:024120	-0.009x
N.D. Rubber Public Company Limited BK:NDR	0.014x

Annual Cash Flow Conversion Efficiency for Eutilex.Co.Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Eutilex.Co.Ltd from 2016 to 2024. Review 263050 financial flexibility score to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩39.94 Billion ≈ $27.07 Million	₩-21.40 Billion ≈ $-14.50 Million	-0.536x	-26.63%
2023-12-31	₩60.44 Billion ≈ $40.96 Million	₩-25.58 Billion ≈ $-17.33 Million	-0.423x	-24.17%
2022-12-31	₩87.75 Billion ≈ $59.47 Million	₩-29.90 Billion ≈ $-20.26 Million	-0.341x	+13.88%
2021-12-31	₩68.38 Billion ≈ $46.34 Million	₩-27.06 Billion ≈ $-18.34 Million	-0.396x	-30.05%
2020-12-31	₩58.51 Billion ≈ $39.65 Million	₩-17.80 Billion ≈ $-12.07 Million	-0.304x	-42.14%
2019-12-31	₩62.83 Billion ≈ $42.58 Million	₩-13.45 Billion ≈ $-9.11 Million	-0.214x	-62.31%
2018-12-31	₩77.49 Billion ≈ $52.52 Million	₩-10.22 Billion ≈ $-6.93 Million	-0.132x	-24.07%
2017-12-31	₩51.13 Billion ≈ $34.65 Million	₩-5.44 Billion ≈ $-3.68 Million	-0.106x	+25.20%
2016-12-31	₩25.87 Billion ≈ $17.53 Million	₩-3.68 Billion ≈ $-2.49 Million	-0.142x	--

About Eutilex.Co.Ltd

KQ:263050 Korea Biotechnology

Market Cap

$23.94 Million

₩35.32 Billion KRW

Market Cap Rank

#24376 Global

#1741 in Korea

Share Price

₩959.00

Change (1 day)

+29.95%

52-Week Range

₩683.00 - ₩1480.00

All Time High

₩41553.86